X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Letters in Drug Design & Discovery

期刊標題檢索 LETT DRUG DES D 最新評論: Hello, I would like to ask who should the reminder letter be sent to? ... (2023-05-18)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Letters in Drug Design & Discovery]您好,您是該頁面的第 41268 位訪客。

期刊簡介
期刊名稱Letters in Drug Design & Discovery Letters in Drug Design & Discovery
LetPub Score
5.1
50 ratings
Rate

Reputation
6.4

Influence
3.7

Speed
7.0

期刊簡稱LETT DRUG DES DISCOV
ISSN1570-1808
E-ISSN1875-628X
h-index28
CiteScore
CiteScoreSJRSNIPCiteScore Rank
1.800.2220.364
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q3107 / 183
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Drug Discovery
Q4125 / 157
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Molecular Medicine
Q4154 / 178

自引率 (2023-2024)8.30%自引率趨勢
掲載範囲
Aims & Scope

Letters in Drug Design & Discovery publishes letters, mini-reviews, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of latest Internet technology for both submission and review of manuscripts. The online journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.
官方網站http://benthamscience.com/journal/index.php?journalID=lddd
在線稿件提交http://benthamscience.com/journals/letters-in-drug-design-and-discovery/submit-abstracts-online/#top
開放訪問No
出版商Bentham Science Publishers B.V.
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年2004
每年文章數183每年文章數趨勢
黃金OA百分比1.10%
Web of Science 四分位
2023-2024
WOS Quartile: Q4

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CHEMISTRY, MEDICINALSCIEQ466/72
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1570-1808%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 3.0 month(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【Letters in Drug Design & Discovery】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    JOURNAL OF MEDICINAL CHEMISTRYH-index: 240

    CiteScore: 12.80
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRYH-index: 135

    CiteScore: 11.70
    Marine DrugsH-index: 84

    CiteScore: 9.60
    MINI-REVIEWS IN MEDICINAL CHEMISTRYH-index: 79

    CiteScore: 7.80
    CURRENT TOPICS IN MEDICINAL CHEMISTRYH-index: 104

    CiteScore: 6.40
    MEDICINAL CHEMISTRY RESEARCHH-index: 38

    CiteScore: 4.70
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERSH-index: 133

    CiteScore: 5.70
    Medicinal ChemistryH-index: 39

    CiteScore: 4.30
    NATURAL PRODUCT RESEARCHH-index: 42

    CiteScore: 5.10
    Records of Natural ProductsH-index: 24

    CiteScore: 3.10
    學科內最受檢索的期刊 頁面查看次數
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY289171
    JOURNAL OF MEDICINAL CHEMISTRY282071
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS156782
    NATURAL PRODUCT RESEARCH152626
    Marine Drugs151682
    MEDICINAL CHEMISTRY RESEARCH56606
    CURRENT TOPICS IN MEDICINAL CHEMISTRY49696
    Medicinal Chemistry48986
    MINI-REVIEWS IN MEDICINAL CHEMISTRY37962
    Records of Natural Products33193
  •  

    Letters in Drug Design & Discovery Letters in Drug Design & Discovery
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Letters in Drug Design & Discovery] 的評論撰寫評論
作者: 乐观


領域: 化学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-18 00:17:21 評論於
Hello, I would like to ask who should the reminder letter be sent to? There is no email address for the editor.
(0) 讚! | 乐观

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-08-20 17:16:00 評論於
Journal Homepage URL: http://www.benthamscience.com/lddd/
(0) 讚! | 匿名

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2010-11-08 20:53:00 評論於
There are three reviewers and they ask a lot of questions. They agreed to refuse the article, but the editor encouraged acceptance with revisions. I think there is hope after the overhaul.

(0) 讚! | 匿名

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Letters in Drug Design & Discovery] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*